Insmed Inc
(INSM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INSM | ALNY | BIIB | ||
| Company | Insmed Inc | Alnylam Pharmaceuticals | Biogen Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 149.49 | 322.14 | 188.35 | ||
| High | 149.83 | 325.04 | 192.00 | ||
| Low | 145.36 | 317.80 | 187.20 | ||
| Latest | 148.43 | 322.28 | 191.20 | ||
| Change | -0.12 | -0.70 | +2.21 | ||
| % Change | -0.08% | -0.22% | +1.17% | ||
| Volume | 1,496,100 | 1,582,100 | 996,900 | ||
| 20-Day Average Volume | 2,349,570 | 1,579,060 | 1,708,045 | ||
| Previous Close | 148.55 | 322.98 | 188.99 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 156.23 | 347.62 | 178.28 | ||
| 20-Day Raw Stochastic | 15.27% | 7.58% | 73.34% | ||
| 20-Day Relative Strength | 35.90 | 31.39 | 59.47 | ||
| Weighted Alpha | +57.30 | +6.22 | +48.99 | ||
| Today's Opinion | 8% Sell | 88% Sell | 100% Buy | ||
| Previous Opinion | 8% Sell | 72% Sell | 88% Buy | ||
| Last Month's Opinion | 24% Buy | 40% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.63% since 02/04/26 | -8.43% since 02/04/26 | +3.10% since 02/04/26 | ||
| Low | 145.36 on 02/11/26 | 317.80 on 02/11/26 | 184.54 on 02/05/26 | ||
| High | 156.52 on 02/05/26 | 350.49 on 02/05/26 | 202.41 on 02/06/26 | ||
| 1-Month | |||||
| %Chg | -15.65% since 01/09/26 | -19.08% since 01/09/26 | +1.91% since 01/09/26 | ||
| Low | 145.36 on 02/11/26 | 317.80 on 02/11/26 | 160.36 on 01/20/26 | ||
| High | 175.12 on 01/12/26 | 378.61 on 01/12/26 | 202.41 on 02/06/26 | ||
| 3-Month | |||||
| %Chg | -23.37% since 11/11/25 | -28.69% since 11/11/25 | +19.83% since 11/11/25 | ||
| Low | 145.36 on 02/11/26 | 317.80 on 02/11/26 | 158.05 on 11/12/25 | ||
| High | 212.75 on 12/02/25 | 479.79 on 12/03/25 | 202.41 on 02/06/26 | ||
| 6-Month | |||||
| %Chg | +31.48% since 08/11/25 | -25.91% since 08/11/25 | +49.37% since 08/11/25 | ||
| Low | 112.48 on 08/12/25 | 317.80 on 02/11/26 | 128.25 on 08/12/25 | ||
| High | 212.75 on 12/02/25 | 495.55 on 10/20/25 | 202.41 on 02/06/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 31,681,704 | 42,670,176 | 27,735,984 | ||
| Shares Outstanding, K | 213,273 | 132,114 | 146,759 | ||
| Annual Sales | 363,710,000 | 2,248,240,000 | 9,890,600,000 | ||
| Annual Net Income | -913,770,000 | -278,160,000 | 1,292,900,000 | ||
| Last Quarter Sales | 142,340,000 | 1,249,030,000 | 2,279,400,000 | ||
| Last Quarter Net Income | -370,020,000 | 251,080,000 | -48,900,000 | ||
| 60-Month Beta | 1.11 | 0.35 | 0.16 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.75 on 10/30/25 | 2.90 on 10/30/25 | 1.99 on 02/06/26 | ||
| Latest Earnings Date | 02/19/26 | 02/12/26 | 05/07/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 1,391.30 | 12.68 | ||